Ovarian activity suppression

"Ovarian activity suppression" refers to intentional inhibition of ovarian function, primarily to reduce estrogen and/or progesterone production. This is a therapeutic approach rather than a specific, druggable molecular target. Agents used for ovarian suppression include: - Gonadotrophin-releasing hormone (GnRH) agonists and antagonists, which inhibit pituitary gonadotrophin secretion and thus decrease ovarian steroidogenesis. - Surgical oophorectomy (ovary removal). - Chemotherapy or radiotherapy may also induce ovarian suppression as a side effect. The main application is in hormone-sensitive cancers (e.g., breast cancer), where suppression of ovarian steroid hormones is desired[2]. Mechanistically, these interventions act at the level of the hypothalamic-pituitary-ovarian axis, suppressing gonadotrophin (LH/FSH) secretion and ovarian steroid hormone output. Summary: "Ovarian activity suppression" is not itself a therapeutic molecular target but describes the effect of interventions—primarily drugs targeting hormone receptors (like GnRH receptors)—on ovarian function. Queries about this as a molecular target are incorrect; more precise targets would include "Gonadotrophin-releasing hormone receptor" or "Estrogen receptor," not the suppression process itself[2].

Other names

ovarian suppressionsuppression of ovarian functionovarian function suppression